Comirnaty Omicron XBB.1.5 ([Pfizer] 6 months to <5 years formulation [maroon cap])

Registered for use in people aged 6 months-<5 years

COVID-19 vaccine containing nucleoside-modified mRNA encoding the spike glycoproteins of SARS-CoV-2 Omicron XBB.1.5 strain.  

Multi dose vial without preservative containing 0.4 mL of concentrated suspension for injection vaccine. Requires dilution with 2.2mL of 0.9% sodium chloride. Each vial contains 10 doses in 0.2mL.

Each 0.2 mL dose contains:

• 3 µg mRNA encoding the SARS-CoV-2 Omicron XBB.1.5 spike glycoprotein  
• ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315) 
• 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159)
• Distearoylphosphatidylcholine (DSPC)  
• Cholesterol  
• Trometamol  
• Trometamol hydrochloride  
• Sucrose  
• Water for injections 

For Product Information and Consumer Medicine Information about Comirnaty Omicron XBB.1.5 ([Pfizer] 6 months to <5 years formulation [maroon cap]) visit the Therapeutic Goods Administration website.